This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, J. M.-F. Articles by Ng, I. O.-L. Search for Related Content PubMed PubMed Citation Articles by Lee, J. M.-F. Articles by Ng, I. O.-L.

Hepatitis B Virus–Associated Multistep Hepatocarcinogenesis: A Stepwise Increase in Allelic Alterations

Liver Cancer and Hepatitis Research Laboratory and S. H. Ho Foundation Research Laboratories, Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong

Requests for reprints: Irene O.L. Ng, Room 127B, UPB, Department of Pathology, The University of Hong Kong, Queen Mary Hospital, 102, Pokfulam Road, Hong Kong. Phone: 852-2855-3967; Fax: 852-2872-5197; E-mail: iolng{at}hkucc.hku.hk.

Key Words: genome-wide allelotyping • loss of heterozygosity • cirrhosis • dysplastic nodules • hepatocellular carcinoma

Hepatocarcinogenesis is a multistep process, but systematic analysis using a genetic or molecular approach to accurately delineate the different stages of hepatocellular carcinoma (HCC) development is scarce. In this study, we used genome-wide allelotyping to systematically evaluate the allelic alterations in the multisteps of hepatitis B virus–associated hepatocarcinogenesis. The overall fractional allelic loss (FAL) indices of cirrhosis, dysplastic nodules (DN), and HCC were significantly different, with a clear stepwise increase (P < 0.001). Loss of heterozygosity (LOH) was uncommon in cirrhotic livers (n = 24; mean FAL index ± SD, 0.09 ± 0.09; median, 0.07). In contrast, LOH was common in our 74 HCC nodules, which were predominantly hepatitis B virus–associated (mean FAL index ± SD, 0.40 ± 0.23; median, 0.38). The 18 DNs had FAL index (mean ± SD, 0.27 ± 0.19; median, 0.20) in between that of cirrhosis and HCC. Importantly, high-grade DNs had FAL index significantly higher than that of low-grade DNs (P = 0.031) and close to that of HCC, indicating that high-grade DNs were genetically closer to HCC. However, there was no significant difference in FAL indices between primary HCCs and their corresponding intrahepatic metastases, but this absence of major allelic losses in this transformation to a metastatic phenotype does not exclude small-scale chromosomal losses or gene deletions. To conclude, hepatitis B virus–associated hepatocarcinogenesis is a multistep process accompanied by stepwise increase in allelic losses from cirrhosis and low- and high-grade DN to HCC. Such allelic losses contribute to promote tumor development and progression. [Cancer Res 2008;68(14):5988–96]

This article has been cited by other articles:

				K. M.-F. Sze, Y.-P. Ching, D.-Y. Jin, and I. O.-L. Ng Role of a Novel Splice Variant of Mitotic Arrest Deficient 1 (MAD1), MAD1{beta}, in Mitotic Checkpoint Control in Liver Cancer Cancer Res., November 15, 2008; 68(22): 9194 - 9201. [Abstract] [Full Text] [PDF]